{
    "medicine_id": "2465eb1627eb91adbc02970276834d0bee9bb0c7",
    "platform_id": "DB09107",
    "metadata": {
        "name": "Mircera 50 \u03bcg 0 3ml Injection solution",
        "composition": "50 \u03bcg 0 3ml Methoxy polyethylene glycol epoetin beta",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of patients with anaemia associated with chronic kidney disease Not a substitute for RBC transfusion if immediate correction of anemia is required",
            "contraindications": {
                "disease": "Overdosage can cause severe hypertension",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Stimulates hemoglobin production by stimulating the erythropoetin receptor of erythroid progenitor cells in the bone marrow Hemoglobin increase following a single initial dose occurs 7 to 15 days after",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of Thrombosis can be increased when Peginterferon alfa 2a is combined with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of Thrombosis can be increased when Pegaspargase is combined with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cetuximab"
                    },
                    {
                        "drugbank-id": "DB00004",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Denileukin diftitox"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00023",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Octreotide"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bevacizumab"
                    },
                    {
                        "drugbank-id": "DB00179",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Masoprocol"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00236",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pipobroman"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Chlorotrianisene"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pamidronic acid"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bleomycin"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Megestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00385",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Valrubicin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trifluridine"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00523",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00707",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Porfimer sodium"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00791",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Uracil mustard"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00855",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Aminolevulinic acid"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Testolactone"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00947",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fulvestrant"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00990",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Exemestane"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Letrozole"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trilostane"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trimetrexate"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Estramustine"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Anastrozole"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Panitumumab"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 8 azaguanine"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB01933",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 7 Hydroxystaurosporine"
                    },
                    {
                        "drugbank-id": "DB02109",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Hadacidin"
                    },
                    {
                        "drugbank-id": "DB02342",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 2 Methoxyestradiol"
                    },
                    {
                        "drugbank-id": "DB02424",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Geldanamycin"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB02640",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fumagillin"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB03172",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tubercidin"
                    },
                    {
                        "drugbank-id": "DB03459",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sparfosic acid"
                    },
                    {
                        "drugbank-id": "DB03496",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alvocidib"
                    },
                    {
                        "drugbank-id": "DB03509",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 2 4 Chlorophenyl 5 Quinoxalinecarboxamide"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Brequinar"
                    },
                    {
                        "drugbank-id": "DB03695",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Piritrexim"
                    },
                    {
                        "drugbank-id": "DB03825",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rhodamine 6G"
                    },
                    {
                        "drugbank-id": "DB03880",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Batimastat"
                    },
                    {
                        "drugbank-id": "DB03946",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 3 4 Dihydroxybenzoic Acid"
                    },
                    {
                        "drugbank-id": "DB04106",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fotemustine"
                    },
                    {
                        "drugbank-id": "DB04222",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sparsomycin"
                    },
                    {
                        "drugbank-id": "DB04253",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tretazicar"
                    },
                    {
                        "drugbank-id": "DB04258",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Seocalcitol"
                    },
                    {
                        "drugbank-id": "DB04331",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Monastrol"
                    },
                    {
                        "drugbank-id": "DB04440",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nebularine"
                    },
                    {
                        "drugbank-id": "DB04468",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Afimoxifene"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04655",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Metoprine"
                    },
                    {
                        "drugbank-id": "DB04690",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Camptothecin"
                    },
                    {
                        "drugbank-id": "DB04786",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Suramin"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04849",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cediranib"
                    },
                    {
                        "drugbank-id": "DB04858",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tirapazamine"
                    },
                    {
                        "drugbank-id": "DB04865",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Omacetaxine mepesuccinate"
                    },
                    {
                        "drugbank-id": "DB04866",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Halofuginone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04894",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vapreotide"
                    },
                    {
                        "drugbank-id": "DB04900",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Thymalfasin"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Galiximab"
                    },
                    {
                        "drugbank-id": "DB04907",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sitimagene ceradenovec"
                    },
                    {
                        "drugbank-id": "DB04950",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ranpirnase"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pirfenidone"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Epratuzumab"
                    },
                    {
                        "drugbank-id": "DB04960",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tipifarnib"
                    },
                    {
                        "drugbank-id": "DB04961",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Troxacitabine"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oregovomab"
                    },
                    {
                        "drugbank-id": "DB04975",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Banoxantrone"
                    },
                    {
                        "drugbank-id": "DB04977",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Plitidepsin"
                    },
                    {
                        "drugbank-id": "DB04996",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Satraplatin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05022",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Amonafide"
                    },
                    {
                        "drugbank-id": "DB05076",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fenretinide"
                    },
                    {
                        "drugbank-id": "DB05088",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tetrathiomolybdate"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Labetuzumab"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05129",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Elsamitrucin"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bavituximab"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB05265",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ecabet"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rindopepimut"
                    },
                    {
                        "drugbank-id": "DB05424",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB05428",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Motexafin gadolinium"
                    },
                    {
                        "drugbank-id": "DB05482",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 7 ethyl 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB05524",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pelitinib"
                    },
                    {
                        "drugbank-id": "DB05540",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alanosine"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ramucirumab"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Farletuzumab"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Veltuzumab"
                    },
                    {
                        "drugbank-id": "DB05668",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Palifosfamide"
                    },
                    {
                        "drugbank-id": "DB05697",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with AP 12009"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB05779",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oglufanide"
                    },
                    {
                        "drugbank-id": "DB05786",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Irofulven"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with CT 011"
                    },
                    {
                        "drugbank-id": "DB05974",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Transcrocetinate"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Glembatumumab vedotin"
                    },
                    {
                        "drugbank-id": "DB06013",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Aldoxorubicin"
                    },
                    {
                        "drugbank-id": "DB06021",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with AV 412"
                    },
                    {
                        "drugbank-id": "DB06040",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Filanesib"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Olaratumab"
                    },
                    {
                        "drugbank-id": "DB06159",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rubitecan"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06163",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Plevitrexed"
                    },
                    {
                        "drugbank-id": "DB06171",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06181",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with IMO 2055"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ipilimumab"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nimotuzumab"
                    },
                    {
                        "drugbank-id": "DB06193",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pixantrone"
                    },
                    {
                        "drugbank-id": "DB06195",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Seliciclib"
                    },
                    {
                        "drugbank-id": "DB06199",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Atrasentan"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vadimezan"
                    },
                    {
                        "drugbank-id": "DB06246",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Exisulind"
                    },
                    {
                        "drugbank-id": "DB06263",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Amrubicin"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lonidamine"
                    },
                    {
                        "drugbank-id": "DB06272",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Maxacalcitol"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Elotuzumab"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06365",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sapacitabine"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pertuzumab"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06420",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Annamycin"
                    },
                    {
                        "drugbank-id": "DB06423",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Endostatin"
                    },
                    {
                        "drugbank-id": "DB06433",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tezacitabine"
                    },
                    {
                        "drugbank-id": "DB06436",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Semaxanib"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06461",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Squalamine"
                    },
                    {
                        "drugbank-id": "DB06478",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Porfiromycin"
                    },
                    {
                        "drugbank-id": "DB06517",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with MLN576"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Catumaxomab"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Axitinib"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Volociximab"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ofatumumab"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Methyltestosterone"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06748",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ginsenoside C"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Hydroxyprogesterone caproate"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB06810",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07232",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Veliparib"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Hexestrol"
                    },
                    {
                        "drugbank-id": "DB08313",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nocodazole"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Puromycin"
                    },
                    {
                        "drugbank-id": "DB08486",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Efaproxiral"
                    },
                    {
                        "drugbank-id": "DB08633",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with TNP 470"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vismodegib"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB08886",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Asparaginase Erwinia chrysanthemi"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Formestane"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08913",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Radium Ra 223 dichloride"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09010",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carmofur"
                    },
                    {
                        "drugbank-id": "DB09031",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Miltefosine"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dienogest"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sonidegib"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tegafur"
                    },
                    {
                        "drugbank-id": "DB09274",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Artesunate"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ixazomib"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alectinib"
                    },
                    {
                        "drugbank-id": "DB11366",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Roquinimex"
                    },
                    {
                        "drugbank-id": "DB11526",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Masitinib"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11617",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Aclarubicin"
                    },
                    {
                        "drugbank-id": "DB11618",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Zorubicin"
                    },
                    {
                        "drugbank-id": "DB11630",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Temoporfin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11651",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dactolisib"
                    },
                    {
                        "drugbank-id": "DB11662",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rabusertib"
                    },
                    {
                        "drugbank-id": "DB11669",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ortataxel"
                    },
                    {
                        "drugbank-id": "DB11678",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Treosulfan"
                    },
                    {
                        "drugbank-id": "DB11688",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 2 chloroethyl 3 sarcosinamide 1 nitrosourea"
                    },
                    {
                        "drugbank-id": "DB11694",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ilorasertib"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11716",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Misonidazole"
                    },
                    {
                        "drugbank-id": "DB11717",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Epacadostat"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB11727",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Endostar"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Icotinib"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Talazoparib"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11793",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Niraparib"
                    },
                    {
                        "drugbank-id": "DB11795",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with GSK 2636771"
                    },
                    {
                        "drugbank-id": "DB11800",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tivozanib"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB11812",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Talaporfin"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11832",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Crenolanib"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB11880",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Acridine Carboxamide"
                    },
                    {
                        "drugbank-id": "DB11886",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Infigratinib"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11894",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Efatutazone"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11907",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rociletinib"
                    },
                    {
                        "drugbank-id": "DB11918",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Guadecitabine"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 6 O benzylguanine"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Binimetinib"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11973",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tesevatinib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11999",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vosaroxin"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Abemaciclib"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alpelisib"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12028",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Broxuridine"
                    },
                    {
                        "drugbank-id": "DB12036",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Naquotinib"
                    },
                    {
                        "drugbank-id": "DB12056",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trebananib"
                    },
                    {
                        "drugbank-id": "DB12081",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Anecortave"
                    },
                    {
                        "drugbank-id": "DB12082",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vesnarinone"
                    },
                    {
                        "drugbank-id": "DB12083",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mafosfamide"
                    },
                    {
                        "drugbank-id": "DB12085",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with LCL 161"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12108",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Taselisib"
                    },
                    {
                        "drugbank-id": "DB12124",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Namitecan"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lorlatinib"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12146",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rigosertib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB12156",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cordycepin"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12182",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Binetrakin"
                    },
                    {
                        "drugbank-id": "DB12185",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Exatecan"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12222",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lurtotecan"
                    },
                    {
                        "drugbank-id": "DB12232",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with KRN 7000"
                    },
                    {
                        "drugbank-id": "DB12257",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Platinum"
                    },
                    {
                        "drugbank-id": "DB12259",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with CG 200745"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB12279",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with OBP 801"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12340",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Navitoclax"
                    },
                    {
                        "drugbank-id": "DB12352",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bizelesin"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12379",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Indirubin"
                    },
                    {
                        "drugbank-id": "DB12381",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Merestinib"
                    },
                    {
                        "drugbank-id": "DB12382",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with R 306465"
                    },
                    {
                        "drugbank-id": "DB12385",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12422",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sulforaphane"
                    },
                    {
                        "drugbank-id": "DB12459",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Belotecan"
                    },
                    {
                        "drugbank-id": "DB12473",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Taurolidine"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Copanlisib"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with 9 aminocamptothecin"
                    },
                    {
                        "drugbank-id": "DB12525",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Molgramostim"
                    },
                    {
                        "drugbank-id": "DB12539",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oltipraz"
                    },
                    {
                        "drugbank-id": "DB12549",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pyrazoloacridine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12577",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fosbretabulin"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12593",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Apaziquone"
                    },
                    {
                        "drugbank-id": "DB12596",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Combretastatin"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12637",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Onapristone"
                    },
                    {
                        "drugbank-id": "DB12638",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with PU H71"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12671",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Beloranib"
                    },
                    {
                        "drugbank-id": "DB12677",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Soblidotin"
                    },
                    {
                        "drugbank-id": "DB12681",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Salirasib"
                    },
                    {
                        "drugbank-id": "DB12688",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Moxetumomab Pasudotox"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12695",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Phenethyl Isothiocyanate"
                    },
                    {
                        "drugbank-id": "DB12697",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Methylselenocysteine"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12730",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dolastatin 10"
                    },
                    {
                        "drugbank-id": "DB12736",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Etanidazole"
                    },
                    {
                        "drugbank-id": "DB12769",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lometrexol"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12832",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Prednimustine"
                    },
                    {
                        "drugbank-id": "DB12870",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Buthionine Sulfoximine"
                    },
                    {
                        "drugbank-id": "DB12873",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dianhydrogalactitol"
                    },
                    {
                        "drugbank-id": "DB12881",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Indole 3 carbinol"
                    },
                    {
                        "drugbank-id": "DB12901",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fiacitabine"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12912",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nolatrexed"
                    },
                    {
                        "drugbank-id": "DB12916",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitolactol"
                    },
                    {
                        "drugbank-id": "DB12920",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pinometostat"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12948",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Didox"
                    },
                    {
                        "drugbank-id": "DB12967",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitoguazone"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB12987",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Penclomedine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13005",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rebastinib"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13046",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tocladesine"
                    },
                    {
                        "drugbank-id": "DB13066",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Liarozole"
                    },
                    {
                        "drugbank-id": "DB13069",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nimustine"
                    },
                    {
                        "drugbank-id": "DB13104",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with X 396"
                    },
                    {
                        "drugbank-id": "DB13128",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Sizofiran"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nedaplatin"
                    },
                    {
                        "drugbank-id": "DB13164",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Olmutinib"
                    },
                    {
                        "drugbank-id": "DB13182",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Daidzein"
                    },
                    {
                        "drugbank-id": "DB13243",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tiazofurine"
                    },
                    {
                        "drugbank-id": "DB13304",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Triaziquone"
                    },
                    {
                        "drugbank-id": "DB13318",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Demecolcine"
                    },
                    {
                        "drugbank-id": "DB13334",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mannosulfan"
                    },
                    {
                        "drugbank-id": "DB13339",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Etoglucid"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13480",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lentinan"
                    },
                    {
                        "drugbank-id": "DB13543",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitobronitol"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13647",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Semustine"
                    },
                    {
                        "drugbank-id": "DB13677",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Carboquone"
                    },
                    {
                        "drugbank-id": "DB13767",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vorozole"
                    },
                    {
                        "drugbank-id": "DB13809",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Paclitaxel poliglumex"
                    },
                    {
                        "drugbank-id": "DB13811",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Oblimersen"
                    },
                    {
                        "drugbank-id": "DB13832",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ranimustine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13877",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Iniparib"
                    },
                    {
                        "drugbank-id": "DB13896",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Talimogene laherparepvec"
                    },
                    {
                        "drugbank-id": "DB13912",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Coumermycin A1"
                    },
                    {
                        "drugbank-id": "DB13916",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Toyocamycin"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tretamine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14067",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dofequidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14680",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Combretastatin A4"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB14731",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tagraxofusp"
                    },
                    {
                        "drugbank-id": "DB14765",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Rivoceranib"
                    },
                    {
                        "drugbank-id": "DB14792",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with AZD 5991"
                    },
                    {
                        "drugbank-id": "DB14844",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with ONC 201"
                    },
                    {
                        "drugbank-id": "DB14860",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Ensartinib"
                    },
                    {
                        "drugbank-id": "DB14865",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Human interleukin 2"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14951",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Etirinotecan pegol"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Zanubrutinib"
                    },
                    {
                        "drugbank-id": "DB15057",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with NUC 1031"
                    },
                    {
                        "drugbank-id": "DB15157",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Voruciclib"
                    },
                    {
                        "drugbank-id": "DB15215",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with KRN 5500"
                    },
                    {
                        "drugbank-id": "DB15289",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Perillyl alcohol"
                    },
                    {
                        "drugbank-id": "DB15321",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tefinostat"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Biochanin A"
                    },
                    {
                        "drugbank-id": "DB15351",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Dihematoporphyrin ether"
                    },
                    {
                        "drugbank-id": "DB15366",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with SOR C13"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15419",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Nanatinostat"
                    },
                    {
                        "drugbank-id": "DB15466",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Tallimustine"
                    },
                    {
                        "drugbank-id": "DB12062",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Volasertib"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB15102",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pemigatinib"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB15699",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Brexucabtagene autoleucel"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB11942",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Selinexor"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of pulmonary toxicity can be increased when Methoxy polyethylene glycol epoetin beta is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00019",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00061",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB01839",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Propylene glycol"
                    },
                    {
                        "drugbank-id": "DB03394",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Heptaethylene glycol"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegaptanib"
                    },
                    {
                        "drugbank-id": "DB05202",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Egaptivon pegol"
                    },
                    {
                        "drugbank-id": "DB05321",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with PEG uricase"
                    },
                    {
                        "drugbank-id": "DB05860",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Peginterferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB06022",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with GlycoPEG GCSF"
                    },
                    {
                        "drugbank-id": "DB06293",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegnivacogin"
                    },
                    {
                        "drugbank-id": "DB06325",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegpleranib"
                    },
                    {
                        "drugbank-id": "DB06611",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Pegsunercept"
                    },
                    {
                        "drugbank-id": "DB06811",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Polidocanol"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Peginesatide"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be decreased when used in combination with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The therapeutic efficacy of Peginterferon beta 1a can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB09208",
                        "description": "The therapeutic efficacy of Pegloticase can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB11661",
                        "description": "The therapeutic efficacy of Eptacog alfa pegol activated can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB11707",
                        "description": "The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB12258",
                        "description": "The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB12578",
                        "description": "The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The therapeutic efficacy of Cepeginterferon alfa 2B can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB12839",
                        "description": "The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB12842",
                        "description": "The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB14712",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB00984",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be increased when used in combination with Nandrolone phenpropionate"
                    },
                    {
                        "drugbank-id": "DB08804",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be increased when used in combination with Nandrolone decanoate"
                    },
                    {
                        "drugbank-id": "DB13169",
                        "description": "The therapeutic efficacy of Methoxy polyethylene glycol epoetin beta can be increased when used in combination with Nandrolone"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vintafolide"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vinflunine"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol epoetin beta is combined with Vincamine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}